A clinical trial to study the effects of two drugs, Lacosamide and Pregabalin in patients with Neuropathic pai
- Conditions
- Health Condition 1: G63- Polyneuropathy in diseases classified elsewhere
- Registration Number
- CTRI/2020/03/023953
- Lead Sponsor
- SRM College of Pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients with definite or probable neuropathic pain for more than 3 months.
Patients who are willing to give informed consent
Patient with concomitant pain syndrome that could affect the pain evaluation such fibromyalgia.
Patients with serious concurrent systemic disease such as liver problems, severe renal impairment, malignancy.
Patients with a history of cardiac arrhythmias or taking antiarrhythmic drugs
Patients with a resting heart rate of less than 55 beats/min or greater than 100 beats/min on electrocardiogram (ECG) screening
Patients on concomitant treatment with antidepressants, other anticonvulsants and opioids that could not be discontinued.
Pregnant women and lactating mothers.
Drug-induced neuropathic pain.
Patients who are not willing to give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method